VRTX
VERTEX PHARMACEUTICALS INC / MA · Healthcare · Market cap $135.6B
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$158.1M
reported sales (SEC code S)
Unique Insiders
13
in the rolling window
Latest filing
Oct 22, 2026
McKechnie Duncan
VERTEX PHARMACEUTICALS INC / MA (VRTX) has 98 SEC Form 4 filings (191 transaction rows) in the rolling window, disclosed by 13 distinct insiders. Most recent filing: Oct 22, 2026.
Inside the rolling window, 13 insiders at VERTEX PHARMACEUTICALS INC / MA reported no open-market purchases and 58 open-market sales totaling $158.1M. The most active filer is EVP and CMO Bozic Carmen with 10 filings. Insiders have net sold $11.0M over the trailing 6 months. The most recent open-market filing is a sale of 1,541 shares by EVP, Chief Commercial Officer McKechnie Duncan, dated Jul 2, 2026, worth $800K.
- Industry:Biotechnology
- CEO:Reshma Kewalramani
- Employees:6,400
- HQ:Boston, MA, US
- IPO:1991-07-24
| Source | |||||||
|---|---|---|---|---|---|---|---|
McKechnie DuncanFirst in 4 months | EVP, Chief Commercial Officer | Sale | 1,541 | $800K | Jul 7 | +2.5% | SEC ↗ |
Tatsis OuraniaFirst in 4 months | EVP, Chief Reg. & Quality Off. | Sale | 1,500 | $787K | Jul 7 | +2.5% | SEC ↗ |
| EVP and Chief Legal Officer | Sale | 828 | $416K | Jul 6 | +1.1% | SEC ↗ | |
| EVP and CMO | Sale | 596 | $288K | Jun 30 | +7.7% | SEC ↗ | |
| EVP and CMO | Sale | 1,020 | $471K | Jun 23 | +14.3% | SEC ↗ | |
| EVP and CMO | Sale | 4,062 | $1.8M | Jun 17 | +16.6% | SEC ↗ | |
| EVP and CMO | Sale | 1,745 | $785K | Jun 9 | +20.1% | SEC ↗ | |
| EVP and Chief Legal Officer | Sale | 828 | $364K | Jun 3 | +24.9% | SEC ↗ | |
| EVP and CMO | Sale | 1,974 | $888K | Jun 2 | +25.9% | SEC ↗ | |
| EVP and CMO | Sale | 1,354 | $614K | May 19 | +23.2% | SEC ↗ | |
| EVP, Chief Scientific Officer | Sale | 33 | $15K | May 19 | — | SEC ↗ | |
| EVP and CMO | Sale | 6,988 | $3.1M | May 14 | — | SEC ↗ | |
| Director | Sale | 318 | $135K | May 5 | — | SEC ↗ | |
| EVP and Chief Legal Officer | Sale | 1,104 | $469K | May 5 | — | SEC ↗ | |
| EVP and Chief Legal Officer | Sale | 978 | $439K | Apr 3 | — | SEC ↗ | |
| EVP and CMO | Sale | 2,329 | $1.1M | Mar 31 | — | SEC ↗ | |
| EVP and CMO | Sale | 2,329 | $1.1M | Mar 17 | — | SEC ↗ | |
| EVP, Chief Commercial Officer | Sale | 2,633 | $1.3M | Mar 13 | — | SEC ↗ | |
| EVP, Chief Commercial Officer | Sale | 2,437 | $1.2M | Mar 6 | — | SEC ↗ | |
Liu JoyFirst filing | EVP and Chief Legal Officer | Sale | 892 | $442K | Mar 4 | — | SEC ↗ |
Kewalramani ReshmaFirst filing | CEO & President | Sale | 40,000 | $19.7M | Mar 3 | — | SEC ↗ |
Bozic CarmenFirst filing | EVP and CMO | Sale | 2,329 | $1.1M | Mar 3 | — | SEC ↗ |
| SVP & Chief Accounting Officer | Sale | 357 | $173K | Mar 2 | — | SEC ↗ | |
McKechnie DuncanFirst filing | EVP, Chief Commercial Officer | Sale | 4,910 | $2.4M | Feb 26 | — | SEC ↗ |
| EVP, Chief Scientific Officer | Sale | 620 | $302K | Feb 26 | — | SEC ↗ |
Earnings: last 7 quarters
Congress trading VRTX 51 all-time
- RRep. David TaylorSale$1,001 - $15,0002026-08-26
- RRep. David J. TaylorOther$1,001 - $15,0002026-08-25
- RSen. Alan ArmstrongPurchase$1,001 - $15,0002026-03-27
- DRep. Ro KhannaPurchase$1,001 - $15,0002026-04-13
- RRep. David J. TaylorSale$1,001 - $15,0002026-01-29
- RRep. Julia LetlowPurchase$1,001 - $15,0002024-10-23
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does VRTX have?
VERTEX PHARMACEUTICALS INC / MA (VRTX) has 98 SEC Form 4 filings (191 transaction rows) in the rolling 365-day window, disclosed by 13 distinct insiders. Most recent filing: Oct 22, 2026.
When was the most recent SEC Form 4 filing for VRTX?
The most recent Form 4 filing for VRTX on Tracefour is dated Oct 22, 2026.
Who is the most active insider at VRTX?
The most active SEC Form 4 filer at VRTX in the rolling window is EVP and CMO Bozic Carmen, with 10 filings.
What is the net insider flow at VRTX over the last 6 months?
Over the trailing 180 days, insiders at VRTX have net sold $11.0M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at VRTX in the current window?
Inside the rolling window, insiders at VRTX bought $0 and sold $158.1M based on SEC Form 4 filings.
Can I get alerts for VRTX insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at VERTEX PHARMACEUTICALS INC / MA (VRTX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
VERTEX PHARMACEUTICALS INC / MA is in the Healthcare sector.